The market for autoimmune disease diagnosis consists of sales of diagnostic assay kits, reagents, consumables and instruments used for the diagnosis of autoimmune diseases. Autoimmune diseases are the diseases in which the production of antibodies takes place in the body which attacks and destroys own healthy cells in the body.
The global autoimmune disease diagnosis market is expected to decline from $3.58 billion in 2019 to $3.08 billion in 2020 at a compound annual growth rate (CAGR) of -13.99%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $4.55 billion in 2023 at a CAGR of 13.96%.
